Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Baxter Plans $146.5 Million Investment In China Dialysis-Related Plants

This article was originally published in PharmAsia News

Executive Summary

Baxter International plans to invest $146.5 million in China to increase production capacity for dialysis products at four of its plants. The U.S.-based company plans to expand its products relying on intravenous and peritoneal solutions to meet Baxter China General Manager Paul Vibert's goal of double-digit sales growth this year. Baxter has plants in Guangzhou, Suzhou, Tianjin and Shanghai. (Click here for more

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts